GRADE RECLASSIFICATION IN ACTIVE SURVEILLANCE FOR AFRICAN AMERICAN MEN WITH VERY LOW RISK PROSTATE CANCER

被引：0
|
作者：
Simopoulos, Demetrios
Landis, Patricia
Epstein, Jonathan
Carter, H. Ballentine
Gorin, Michael
Mamawala, Mufaddal
机构：
来源：
JOURNAL OF UROLOGY | 2019年 / 201卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
MP48-09
引用
收藏
页码：E700 / E700
页数：1
相关论文
共 50 条
  • [41] TREATMENT IN THE ABSENCE OF DISEASE RECLASSIFICATION AMONG MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER
    Kirk, Peter
    Newcomb, Lisa
    Zhu, Kehao
    Zheng, Yingye
    Schenk, Jeannette
    Lin, Daniel
    Gore, John
    JOURNAL OF UROLOGY, 2021, 206 : E213 - E214
  • [42] African American Men With Very Low-Risk Prostate Cancer Exhibit Adverse Oncologic Outcomes After Radical Prostatectomy: Should Active Surveillance Still Be an Option for Them?
    Sundi, Debasish
    Ross, Ashley E.
    Humphreys, Elizabeth B.
    Han, Misop
    Partin, Alan W.
    Carter, H. Ballentine
    Schaeffer, Edward M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (24) : 2991 - 2997
  • [43] Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden
    Loeb, Stacy
    Folkvaljon, Yasin
    Curnyn, Caitlin
    Robinson, David
    Bratt, Ola
    Stattin, Par
    JAMA ONCOLOGY, 2017, 3 (10) : 1393 - 1398
  • [44] Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer
    Cooperberg, Matthew R.
    Lin, Daniel W.
    Morgan, Todd M.
    Chapin, Brian F.
    Chen, Ronald C.
    Eggener, Scott E.
    JOURNAL OF UROLOGY, 2022, 207 (02): : 262 - 264
  • [45] Prostate cancer active surveillance outcomes in a cohort composed primarily of African American and Hispanic American Men
    Kidd, Laura C.
    Loecher, Matthew
    Ahmed, Nahrin
    Terzian, Joseph
    Song, Jun
    Reese, Adam C.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2021, 39 (10) : 730.e1 - 730.e8
  • [46] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    Tosoian, J. J.
    Patel, H. D.
    Mamawala, M.
    Landis, P.
    Wolf, S.
    Elliott, D. J.
    Epstein, J. I.
    Carter, H. B.
    Ross, A. E.
    Sokoll, L. J.
    Pavlovich, C. P.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2017, 20 (03) : 339 - 342
  • [47] Longitudinal assessment of urinary PCA3 for predicting prostate cancer grade reclassification in favorable-risk men during active surveillance
    J J Tosoian
    H D Patel
    M Mamawala
    P Landis
    S Wolf
    D J Elliott
    J I Epstein
    H B Carter
    A E Ross
    L J Sokoll
    C P Pavlovich
    Prostate Cancer and Prostatic Diseases, 2017, 20 : 339 - 342
  • [48] 5α-reductase inhibitors and the risk of grade reclassification for men with long-term follow-up on active surveillance for prostate cancer.
    Finelli, Antonio
    Timilshina, Narhari
    Komisarenko, Maria
    Sowerby, Robert
    Hamilton, Robert James
    Zlotta, Alexandre
    Fleshner, Neil Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [49] Germline Mutations in ATM and BRCA1/2 Are Associated with Grade Reclassification in Men on Active Surveillance for Prostate Cancer
    Carter, H. Ballentine
    Helfand, Brian
    Mamawala, Mufaddal
    Wu, Yishuo
    Landis, Patricia
    Yu, Hongjie
    Wiley, Kathleen
    Na, Rong
    Shi, Zhuqing
    Petkewicz, Jacqueline
    Shah, Sameep
    Fantus, Richard J.
    Novakovic, Kristian
    Brendler, Charles B.
    Zheng, S. Lilly
    Isaacs, William B.
    Xu, Jianfeng
    EUROPEAN UROLOGY, 2019, 75 (05) : 743 - 749
  • [50] Identifying Men Who Can Remain on Active Surveillance Despite Biopsy Reclassification to Grade Group 2 Prostate Cancer
    Baraban, Ezra
    Erak, Eric
    Fatima, Aisha
    Akbari, Amir
    Zhao, Jianping
    Fletcher, Sean A.
    Bhanji, Yasin
    de la Calle, Claire M.
    Mamawala, Mufaddal
    Landis, Patricia
    Macura, Katarzyna J.
    Pavlovich, Christian P.
    Epstein, Jonathan I.
    JOURNAL OF UROLOGY, 2023, 210 (01): : 99 - 107
12345